BF
AMRI

BOK Financial’s Albany Molecular Research Inc AMRI Stock Holding History

BOK Financial’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-53,200
Closed -$746K – 936
2017
Q1 		$746K Sell
53,200
-311
-0.6% -$5.09K 0.02% 551
2016
Q4 		$1M Sell
53,511
-6,223
-10% -$106K 0.03% 465
2016
Q3 		$986K Sell
59,734
-1,325
-2% -$19.6K 0.03% 475
2016
Q2 		$820K Sell
61,059
-641
-1% -$9.35K 0.03% 482
2016
Q1 		$944K Sell
61,700
-890
-1% -$13.9K 0.03% 441
2015
Q4 		$1.24M Sell
62,590
-450
-0.7% -$8.55K 0.04% 387
2015
Q3 		$1.1M Sell
63,040
-15,550
-20% -$317K 0.04% 403
2015
Q2 		$1.59M Buy
78,590
+20
+0% +$386 0.05% 369
2015
Q1 		$1.38M Buy
+78,570
New +$1.34M 0.05% 380
2014
Q4 		– Sell
-52,260
Closed -$1.15M – 856
2014
Q3 		$1.15M Buy
+52,260
New +$1.07M 0.04% 415

Other funds holding AMRI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CCM
Chicago Capital Management Chicago, Illinois $121M AUM 74.36% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

BOK Financial's AMRI Position: Q2 2017 in Review

BOK Financial sold out of Albany Molecular Research Inc (AMRI) in Q2 2017, closing a stake of 53,200 shares — an estimated $746K sold.

BOK Financial first reported a position in AMRI in Q3 2014 and held it in 10 quarters. The position peaked at $1.59M in Q2 2015. 136 funds tracked by Wall St. Rank hold AMRI as of Q2 2017.

  • BOK Financial reported no remaining Albany Molecular Research Inc position as of Q2 2017 after selling out during the quarter.
  • BOK Financial sold 53,200 Albany Molecular Research Inc shares in Q2 2017, an estimated $746K.
  • BOK Financial first reported a position in Albany Molecular Research Inc in Q3 2014 and held it in 10 quarters.
  • BOK Financial's Albany Molecular Research Inc position peaked at $1.59M in Q2 2015.
  • 136 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q2 2017.

Based on BOK Financial's 13F filing for Q2 2017, filed 14 Aug 2017.